the aid library

Filter

7884

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 9 October 2023

World Health Organization WHO (2023) CC

The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline ... more

Communicable and non-communicable diseases in Africa in 2021/22

World Health Organization Africa Region; WHO Africa World Health Organization Africa Region; WHO Africa (2023) C_WHO

This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra ... more

Internal Medicine Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

Myanmar’s National Adaptation Programme of Action (NAPA) to Climate Change

The Republic of the Union of Myanmar, Ministry of Environmental Conservation and Forestry, National Environmental Conservation Committee (2012) C1

Sectors in which Priority Adaptation Projects should be implemented first include:
- 1) Agriculture, Early Warning Systems and Forest (First Priority Level Sectors). This is followed by:
- 2) Public Health and Water Resources (Second Priority Level Sectors);
- 3) Coastal Zone (Thir ... more

DISABILITY POLICY AUDIT IN NAMIBIA, SWAZILAND, MALAWI AND MOZAMBIQUE (Final Report)

Lang, R SAFOD & DFID (2008) C2

The Leonard Cheshire Disability and Inclusive Development Centre | University College London | 4 Taviton Street | London WC1H OBT | United Kingdom| Principal Investigator: Dr Raymond Lang | Email: r.lang@ucl.ac.uk | Tel: +44 (0)207 679 1519 | Research Commissioned by the Southern African Federation ... more

WHO Living guideline: Drugs to prevent COVID-19
recommended

World Health Organization WHO (2021) C_WHO

Interim guidance 2 march 2021 Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform ... more

Code of Good Practice in the Management and Support of Aid Personnel

People In Aid (2003) CC

Building on previous guidelines, the People In Aid Code seeks to offer agencies an effective framework for human resources management, helping them assess and raise their performance.

UNODC-WHO Stop-Overdose-Safely (‎S-O-S)‎ project implementation in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine

World Health Organization WHO; United Nations Office on Drugs and Crime UNODC (2021) C_WHO

Summary Report

Pediatrics Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

Kenya: Transforming Health: Accelerating Attainment of Universal Health Coverage

Kenya Health Sector Strategic and Investment Plan (KNSSP) (2014) C1

DISABILITY AND REHABILITATION STATUS

World Health Organization (2004)

Review of disability issues and rehabilitation services in 29 african countries.

Standard Operating Procedures - Adherence Guidelines for HIV, TB and NCDs: Training Course for Health Care Workers Participant Guide
recommended

National Department of Health, South Africa (2023) C1

PARTICIPANT GUIDE. This Participant Guide has been designed to assist health facilities and community based non-clinicians to develop skills to provide linkage to care, adherence and retention in care services for chronic conditions

Integrating Mental Health and HIV Services in Zimbabwean Communities: A Nurse and Community-led Approach to Reach the Most Vulnerable

Duffy, M.; M. Sharer, H. Cornman, et al. (2017) CC

JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, Vol. 28, No. 2, March/April 2017, 186-198 http://dx.doi.org/10.1016/j.jana.2015.09.003

Out with it - HIV and Other Sexual Health Considerations for Young Men Who Have Sex with Men

G. Ayala; R. Baggaley; B. Konstantinov; et al. MPact: Global Action for Gay Men’s Health and Rights; World Health Organization; UNDP; UNFPA; (2018) C_WHO

Technical Brief

Anxiety Disorders. An information Guide

Rector, N., D. Bourdeau, K. Kitchen, et al. Centre for Addiction and Mental Health CAMH (2008) CC

Tuberculosis and comorbidities in urban areas in Argentina. A gender and age perspective ,

Echazarreta, A.; Zerbini E. De Sandro j., et al. 2018 (2018) CC

180 Biomédica 2018;38:180-8

Screening for cardiovascular disease risk and subsequent management in low and middle income countries: challenges and opportunities

Bovet, P.; Chiolero, A.; Paccaud, F. et al. Public Health Reviews (2015) CC

Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the leading cause of premature mortality in low and middle income countries (LMICs). Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector ... al population-based interventions to reduce CVD risk factors in the entire population. Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs. Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management. Conclusion: The large burden of CVD in LMICs and the fact that persons with high CVD can be identified and managed along cost-effective interventions mean that health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level. more

Nigeria Integrated Biological and Behavioural Surveillance Survey (IBBSS) 2014

National AIDS and STIs Control programme (NASCP), Federal Ministry of Health, Nigeria (2015) C1

Positioning zoonotic disease research in forced migration: A systematic literature review of theoretical frameworks and approaches

Tasker, A.; Braam, D. PLOS ONE (2021) C1

The emergence and transmission of zoonotic diseases are driven by complex interactions between health, environmental, and socio-political systems. Human movement is considered a significant and increasing factor in these processes, yet forced migration remains an understudied area of zoonotic res ... more

WHO best practices for injections and related procedures toolkit

World Health Organization; SIGN (2010) C_WHO

The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.